BioSpace News Archive

Drug Development

Phase 3 IMBRUVICA® (ibrutinib) Data Suggest Improved Treatment Outcomes in Waldenström’s Macroglobulinemia (WM), a Rare Form of Blood Cancer, in Combination with Rituximab versus Rituximab Alone

AbbVie announced findings from an interim analysis of the Phase 3 iNNOVATE (PCYC-1127) study evaluating IMBRUVICA® (ibrutinib) plus RITUXAN® (rituximab).

June 1, 2018
·
15 min read
Primex Pharmaceuticals AG presents ADV6209* at Euroanaesthesia 2018

Swiss company Primex Pharmaceuticals AG presents ADV6209* at Euroanaesthesia 2018.

June 1, 2018
·
2 min read
Business

Nordic Nanovector Strengthens Management Team With Appointment of Maureen Deehan, PhD, as Head of Corporate Development and Strategy

Nordic Nanovector ASA (OSE: NANO) announces that Maureen Deehan, PhD, has been appointed as Head of Corporate Development and Strategy.

June 1, 2018
·
2 min read
CENTOGENE to Present at the Jefferies 2018 Global Healthcare Conference

CENTOGENE announced that Richard Stoffelen, Chief Financial Officer of CENTOGENE, will present at the upcoming Jefferies 2018 Global Healthcare Conference.

June 1, 2018
·
1 min read
Samsung Bioepis Announces Results of Additional One-Year Follow-up Study on SB3 Trastuzumab Biosimilar Candidate at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

Additional one-year follow-up study results show low incidence of cardiac safety events and no statistically significant difference in survival results compared to reference trastuzumab in the SB3 treatment group

June 1, 2018
·
3 min read
BioCapital

Xynomic Pharma Completes Series B Crossover Financing, Starts Four Pivotal Trials in Renal Cell Carcinoma (RCC) and Lymphoma, and Opens a R&D Center

All existing investors including Prosperico Ventures and Mr. Yinglin Mark Xu, Xynomic Pharma’s founder and Chairman, participated in this round of financing.

June 1, 2018
·
2 min read
Unmasking Brain Injury Pulls Back the Curtain on Brain Injuries

Unmasking Brain Injury is an international movement and, through the coordination of the Ontario Brain Injury Association (OBIA), Ontario has become the first province in Canada to participate.

June 1, 2018
·
1 min read
BioMidwest

Exact Sciences to participate in June 2018 investor conferences

Exact Sciences Corp. announced that company management will be presenting at the following investor conferences during June and invited investors to participate by webcast.

June 1, 2018
·
4 min read
Business

NewYork-Presbyterian, Ronald O. Perelman Heart Institute, The City Of New York And The New York City Health Department Team Up For Annual #HandsOnlyCPR Campaign

The Ronald O. Perelman Heart Institute and NewYork-Presbyterian, along with the City of New York and the American Heart Association, are joining forces with the New York City Health Department to launch their second annual #HandsOnlyCPR campaign.

June 1, 2018
·
6 min read
Lone Star Bio

Vizient Applauds FDA Plan to Improve Medical Device Cybersecurity

Vizient expressed support for the Agency’s proactive approach to cybersecurity that will enhance existing programs and processes, enable timely resolution of known safety issues, and encourage innovative technologies that are safer and more effective.

June 1, 2018
·
2 min read